cryolife, headquartered in georgia, is a leader in the processing and distribution of human tissues for use in cardiac and vascular surgeries. cryolife using its proprietary synergraft® technology processes the cryovalve® sg pulmonary heart valve and cryopatch® sg pulmonary cardiac patch. cryolife’s bioglue® surgical adhesive is approved in the u.s. for use as an adjunct to sutures and staples to help control bleeding, ce marked in the european community, approved in canada and australia for use in soft tissue repair, and in japan for use in the repair of aortic dissections. cryolife’s cardiogenesis specializes in the treatment of severe angina using a laser console system and fiber-optic handpieces to perform a surgical procedure known as transmyocardial revascularization (tmr). cryolife markets the hero® graft, which provides vascular access for hemodialysis patients. cryolife distributes perclot®, an absorbable powdered hemostat, in international markets. cryolife’s biofoam® surgica
Company profile
Ticker
AORT
Exchange
Website
CEO
James Mackin
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
CRYOLIFE INC
SEC CIK
Corporate docs
Subsidiaries
Artivion Colombia SAS • Artivion Cyprus Limited • Artivion EMEA GmbH • Artivion Hellas Single Member Ltd. • Artivion Hong Kong, Limited • Artivion LATAM Holdings • Artivion Malaysia, Sdn. Bhd. • Artivion Taiwan Co. Limited • Ascyrus Medical GmbH • Ascyrus Medical LLC ...
IRS number
592417093
AORT stock data
Latest filings (excl ownership)
ARS
2023 FY
Annual report to shareholders
1 Apr 24
DEFA14A
Additional proxy soliciting materials
1 Apr 24
DEF 14A
Definitive proxy
1 Apr 24
PRE 14A
Preliminary proxy
21 Mar 24
S-3ASR
Automatic shelf registration
29 Feb 24
10-K
2023 FY
Annual report
23 Feb 24
8-K
Artivion Reports Fourth Quarter and Full Year 2023 Financial Results
15 Feb 24
8-K
Entry into a Material Definitive Agreement
18 Jan 24
8-K
Artivion Appoints Lance A. Berry as Announces Retirement of D. Ashley Lee, Chief Financial Officer
6 Dec 23
10-Q
2023 Q3
Quarterly report
3 Nov 23
Transcripts
AORT
Earnings call transcript
2023 Q4
15 Feb 24
AORT
Earnings call transcript
2023 Q3
2 Nov 23
AORT
Earnings call transcript
2023 Q2
3 Aug 23
AORT
Earnings call transcript
2023 Q1
4 May 23
AORT
Earnings call transcript
2022 Q4
16 Feb 23
AORT
Earnings call transcript
2022 Q3
3 Nov 22
AORT
Earnings call transcript
2022 Q2
7 Aug 22
AORT
Earnings call transcript
2022 Q1
8 May 22
AORT
Earnings call transcript
2021 Q4
18 Feb 22
AORT
Earnings call transcript
2021 Q3
7 Nov 21
Latest ownership filings
4
Marshall S. Stanton
21 Mar 24
4
ANDREW M GREEN
18 Mar 24
4
ANDREW M GREEN
15 Mar 24
144
Notice of proposed sale of securities
15 Mar 24
4
Matthew A Getz
14 Mar 24
4/A
Amy Horton
14 Mar 24
4/A
Marshall S. Stanton
14 Mar 24
4/A
Rochelle L. Maney
14 Mar 24
4/A
Jean F Holloway
14 Mar 24
4/A
ANDREW M GREEN
14 Mar 24
Financial summary
Quarter (USD) | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 53.48 mm | 53.48 mm | 53.48 mm | 53.48 mm | 53.48 mm | 53.48 mm |
Cash burn (monthly) | (no burn) | (no burn) | 3.14 mm | 544.42 k | (no burn) | (no burn) |
Cash used (since last report) | n/a | n/a | 20.95 mm | 3.63 mm | n/a | n/a |
Cash remaining | n/a | n/a | 32.53 mm | 49.85 mm | n/a | n/a |
Runway (months of cash) | n/a | n/a | 10.4 | 91.6 | n/a | n/a |
Institutional ownership, Q3 2023
82.5% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 140 |
Opened positions | 20 |
Closed positions | 4 |
Increased positions | 38 |
Reduced positions | 48 |
13F shares | Current |
---|---|
Total value | 492.08 bn |
Total shares | 33.99 mm |
Total puts | 6.80 k |
Total calls | 11.20 k |
Total put/call ratio | 0.6 |
Largest owners | Shares | Value |
---|---|---|
BLK Blackrock | 6.72 mm | $101.91 bn |
MCQEF Macquarie | 2.89 mm | $43.76 bn |
Vanguard | 2.65 mm | $40.12 bn |
Wellington Management | 2.51 mm | $38.01 bn |
MS Morgan Stanley | 2.32 mm | $35.17 bn |
Juniper Investment | 2.10 mm | $31.81 bn |
Dimensional Fund Advisors | 1.61 mm | $24.35 bn |
STT State Street | 1.55 mm | $23.44 bn |
GW&K Investment Management | 1.33 mm | $20.19 mm |
Royce & Associates | 988.00 k | $14.98 bn |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
20 Mar 24 | Marshall S. Stanton | Common Stock | Sell | Dispose S | No | No | 20.39 | 2,183 | 44.51 k | 83,296 |
15 Mar 24 | Andrew M Green | Common Stock | Sell | Dispose S | No | Yes | 20 | 1,462 | 29.24 k | 41,121 |
14 Mar 24 | Andrew M Green | Common Stock | Sell | Dispose S | No | Yes | 20 | 3,994 | 79.88 k | 42,583 |
12 Mar 24 | Getz Matthew A | Common Stock | Sell | Dispose S | No | No | 19.9439 | 5,000 | 99.72 k | 43,536 |
5 Mar 24 | Mackin James P | Common Stock | Sell | Dispose S | No | No | 18.7223 | 13,996 | 262.04 k | 705,562 |
1 Mar 24 | Mackin James P | Common Stock | Grant | Acquire A | No | No | 0 | 28,618 | 0.00 | 719,558 |
News
Needham Maintains Buy on Artivion, Maintains $25 Price Target
8 Apr 24
12 Health Care Stocks Moving In Monday's Pre-Market Session
19 Feb 24
Why DoorDash Shares Are Trading Lower By Around 12%? Here Are Other Stocks Moving In Friday's Mid-Day Session
16 Feb 24
Applied Materials Posts Upbeat Earnings, Joins Texas Roadhouse, Vulcan Materials And Other Big Stocks Moving Higher On Friday
16 Feb 24
12 Health Care Stocks Moving In Friday's Pre-Market Session
16 Feb 24
Press releases
Artivion to Participate in the 23rd Annual Needham Virtual Healthcare Conference
1 Apr 24
Artivion to Participate in the Oppenheimer 34th Annual Healthcare MedTech & Services Conference
6 Mar 24
Artivion Announces Release Date and Teleconference Call Details for Fourth Quarter and Full Year 2023 Financial Results
1 Feb 24